GLOMERULONEPHRITIS
Clinical trials for GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for kidney disease in early trial
Disease control CompletedThis early-stage study tested a drug called mezagitamab in 17 people with IgA nephropathy, a kidney disease. The main goal was to check for side effects and see how the body processes the drug. Participants received injections under the skin for several weeks and were monitored f…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for slowing kidney disease in Non-Diabetic patients
Disease control CompletedThis study tested whether finerenone, a drug that blocks a hormone involved in kidney damage, can reduce protein in urine and slow kidney function decline. One hundred adults with non-diabetic glomerulonephritis took either finerenone or a placebo for 9 months, on top of their us…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE2 • Sponsor: Alexandria University • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Steroids for kidney disease: do they prevent failure Long-Term?
Knowledge-focused CompletedThis study follows 211 people with IgA nephropathy who previously took a 6-9 month course of the steroid methylprednisolone in the TESTING trial. Researchers want to see if the steroid helped prevent end-stage kidney disease (needing dialysis or a transplant) over the long term. …
Matched conditions: GLOMERULONEPHRITIS
Sponsor: The George Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC